Stimulation by antipsychotic agents of mitogen-activated protein kinase (MAPK) coupled to cloned, human (h)serotonin (5-HT)1A receptors

Psychopharmacology

Volumn 162, Issue 2, 2002, Pages 168-177

  Cussac, Didier ^a   Duqueyroix, Delphine ^a   Newman Tancredi, Adrian ^a   Millan, Mark J ^a  

^a INSTITUT DE RECHERCHES SERVIER   (France)

Author keywords

5 HT1A; Antipsychotic; Clozapine; Gi protein; Mitogen activated protein kinase; Schizophrenia

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; ALPHA [1 [2 (1,4 BENZODIOXAN 5 YLOXY)ETHYL] 3 PYRROLIDINYL] 4 FLUOROACETOPHENONE; ANTIBODY; CLOZAPINE; HALOPERIDOL; MITOGEN ACTIVATED PROTEIN KINASE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; NEUROLEPTIC AGENT; OCAPERIDONE; OLANZAPINE; QUETIAPINE; RISPERIDONE; SEROTONIN 1A RECEPTOR; SERTINDOLE; THIORIDAZINE; TIOSPIRONE; ZIPRASIDONE; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); PIPERAZINE DERIVATIVE; PYRROLIDINE DERIVATIVE; SEROTONIN 1 RECEPTOR; SEROTONIN AGONIST; SEROTONIN ANTAGONIST; SEROTONIN RECEPTOR; THIAZOLE DERIVATIVE;

ANIMAL CELL; ANTIBODY SPECIFICITY; ARTICLE; CELL CLONE; CHO CELL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; ANIMAL; ENZYME ACTIVATION; HAMSTER; IMMUNOBLOTTING; METABOLISM; PHOSPHORYLATION;

ANIMAL; ANTIPSYCHOTIC AGENTS; CHO CELLS; CLOZAPINE; ENZYME ACTIVATION; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); HAMSTERS; HUMAN; IMMUNOBLOTTING; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PIPERAZINES; PYRROLIDINES; RECEPTORS, SEROTONIN; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; THIAZOLES; ANIMALS; CRICETINAE; HUMANS; RECEPTORS, SEROTONIN, 5-HT1;

EID: 0036019548     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-002-1043-0     Document Type: Article

References (82)

1. 1A receptor causes suppression of anoxia-induced apoptosis via mitogen-activated protein kinase in neuronal HN25 cells
2. 1A agonist actions. I. Neurochemical effects
3. 1A receptor agonist properties of the antipsychotic nemonapride: Comparison with bromerguride and clozapine
4. 1A receptors and intrinsic activity
5. 1D receptors
6. 1A agonist and dexamethasone reversal of para-chloroamphetamine induced loss of MAP-2 and synaptophysin immunoreactivity in adult rat brain
7. Drugs and the treatment of psychiatric disorders
8. 1A receptor by clozapine measured using PET scanning
9. A review of central 5-HT receptors and their function
10. 1A receptors are not involved in clozapine's lack of cataleptogenic potential
11. Risperidone versus clozapine in treatment-resistant chronic schizophrenia: A randomized double-blind study
12. Radioreceptor binding profile of the atypical antipsychotic olanzapine
13. 1A-mediated inhibition of adenylyl cyclase in dorsal raphe of male and female rats
14. 1A receptors expressed in HeLa cells
15. 1A receptor is sensitive not only to inhibitors of phosphatidylinositol 3-kinase but to an inhibitor of phosphatidylcholine hydrolysis
16. 3 receptors mediate mitogen-activated protein kinase activation via a phosphatidylinositol 3-kinase and an atypical protein kinase C-dependent mechanism
17. Ziprasidone 80 mg/day and 160 mg/day in the acute exacerbation of schizophrenia and schizoaffective disorder: A 6-week placebo-controlled trial
18. 1A receptor-mediated Erk activation requires calcium/cal-modulin-dependent receptor endocytosis
19. Activity of "Seroquel" (ICI 204636) in animal models for atypical properties of antipsychotics: A comparison with clozapine
20. 1A receptors in human post-mortem brain
21. Agonist-dependent modulation of G protein-coupled receptor kinase 2 by mitogen-activated protein kinases
22. MAPK and JNK1 and their regulatory kinases MEK1 and MEK4 in adult rat central nervous system
23. 1A receptor antagonist WAY100635
24. Role of MAP kinase in neurons
25. 1A receptor via a G protein βγ-subunit-initiated pathway
26. 1B receptor inverse agonist 1′-methyl-5-[[2′-methyl-4′-(5-methyl-124-oxadiazol-3-yl) biphenyl-4-yl]-2367-tetrahydro-spiro[furo[23-f]indole-34′-piperidine] (SB-224289) potently blocks terminal 5-HT autoreceptor function both in vitro and in vivo
27. Risperidone: A review of its pharmacology and therapeutic potential in the treatment schizophrenia
28. 1A autoreceptor interactions in the rat dorsal raphe nucleus: An in vitro electrophysiological study
29. Augmentation with buspirone: A review
30. Relationship between dopaminergic and serotonergic neuronal activity in the frontal cortex and the action of typical and atypical antipsychotic drugs
31. 1A receptor agonism on antipsychotic drug-induced dopamine in rat striatum and nucleus accumbens
32. 2 receptors may be a mechanism by which atypical antipsychotic drugs preferentially increase dopamine release in rat medial prefrontal cortex
33. Making new connections: Role of ERK/MAP kinase signaling in neuronal plasticity
34. Ziprasidone 40 and 120 mg/day in the acute exacerbation of schizophrenia and schizoaffective disorder: A 4-week placebo-controlled trial
35. A comparison of bd tid dose regimens of quetiapine (Seroquel) in the treatment of schizophrenia
36. 2 receptor antagonists to inhibit methylphenidate-induced behaviors in rats
37. Dopamine the prefrontal cortex and schizophrenia
38. Mitogen-activated protein kinases in schizophrenia
39. 1A receptors and their modulation of the activity of serotoninergic and dopaminergic neurones in rats
40. Signaling from G-protein-coupled receptors to mitogen-activated protein (MAP)-kinase cascades
41. 1A receptors in human brain tissue
42. Antipsychotic profile and side-effect liability of haloperidol risperidone and ocaperidone as predicted from their differential interaction with amphetamine in rats
43. 1A agonists
44. Cognition schizophrenia and the atypical antipsychotic drugs
45. 2 and inhibition of adenylyl cyclase in transfected CHO cells
46. 1A receptors
47. 1A agonist properties: I Receptorial and neurochemical profile in comparison with clozapine and haloperidol
48. 1A agonist properties: II Functional profile in comparison to clozapine and haloperidol
49. 1A agonist properties: III Anxiolytic actions in comparison with clozapine and haloperidol
50. 1A receptor coupled to mitogen-activated protein kinase
51. The behavioral pharmacology of olanzapine a novel "atypical" antipsychotic agent
52. iβγ stimulates mitogen-activated protein kinase via NAD(P)H oxidase and reactive oxygen species upstream of Src in Chinese hamster ovary fibroblasts
53. 35S]GTPγS binding study
54. 3H]-WAY100,635
55. 3H]-WAY100,635 binding affinity ratio: Relationship to efficacy for G-protein activation
56. Is the Ras-MAPK signalling pathway necessary for long-term memory formation?
57. 1A receptors that are negatively coupled to adenylate cyclase in permanently transfected hela cells
58. 2+ current inhibition produced by serotonin in rat dorsal raphe neurons
59. 1A receptors and monoamine uptake sites in vivo?
60. 1A ligands in preclinical behavioral models for antipsychotic and extrapyramidal effects
61. 1A receptors
62. 1A receptor: G protein coupling and signalling pathways
63. 1A receptor agonists on septal cholinergic neurons in culture
64. Receptor pharmacology of neuroleptics: Relation to clinical effects
65. Binding of antipsychotic drugs to human brain receptors: Focus on newer generation compounds
66. 1 of hippocampus
67. 1A receptor activation
68. 1A receptor activation contributes to ziprasidone-induced dopamine release in the rat prefrontal cortex
69. Seroquel: Biochemical profile of a potential atypical antipsychotic
70. Neurochemical and in vivo pharmacological profile of sertindole a limbic-selective neuroleptic compound
71. Ziprasidone (CP-88059): A new antipsychotic with combined dopamine and serotonin receptor antagonist activity
72. 1A receptor system: Possible implications for schizophrenic negative symptomatology
73. 1A receptors control neurite branching during development
74. 1A receptor activation
75. Effect of adjunctive treatment with serotonin-1a agonist tandospirone on memory functions in schizophrenia
76. Oral olanzapine versus oral haloperidol in the maintenance treatment of schizophrenia and related psychoses
77. Involvement of the extracellular signal-regulated kinase cascade for cocaine-rewarding properties
78. 1A receptors expressed in NIH-3T3 cells induces focus formation and potentiates EGF effect on DNA synthesis
79. Effects of local applications of 5-hydroxytryptamine into the dorsal or median raphe nuclei on haloperidol-induced catalepsy in the rat
80. 2 receptors of normal human brain in vitro
81. 1A agonism in two rat in vivo models
82. Controlled dose-response study of sertindole and haloperidol in the treatment of schizophrenia